Cargando…
New Drug Research and Development for Alzheimer’s Pathology: Present and Prospect
Cholinesterase inhibitors and N-methyl-D-aspartic receptor antagonists are currently the main treatments for Alzheimer’s disease (AD), targeting the clinical symptoms of AD. β-amyloid (Aβ) deposition and the highly-phosphorylated Tau protein-induced neurofibrillary tangles are some of the common pat...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Shanghai Municipal Bureau of Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608996/ https://www.ncbi.nlm.nih.gov/pubmed/28955143 http://dx.doi.org/10.11919/j.issn.1002-0829.217045 |